chr19-53894400-C-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002739.5(PRKCG):​c.939+1009C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.439 in 151,864 control chromosomes in the GnomAD database, including 14,805 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.44 ( 14805 hom., cov: 32)

Consequence

PRKCG
NM_002739.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.916

Publications

5 publications found
Variant links:
Genes affected
PRKCG (HGNC:9402): (protein kinase C gamma) Protein kinase C (PKC) is a family of serine- and threonine-specific protein kinases that can be activated by calcium and second messenger diacylglycerol. PKC family members phosphorylate a wide variety of protein targets and are known to be involved in diverse cellular signaling pathways. PKC also serve as major receptors for phorbol esters, a class of tumor promoters. Each member of the PKC family has a specific expression profile and is believed to play distinct roles in cells. The protein encoded by this gene is one of the PKC family members. This protein kinase is expressed solely in the brain and spinal cord and its localization is restricted to neurons. It has been demonstrated that several neuronal functions, including long term potentiation (LTP) and long term depression (LTD), specifically require this kinase. Knockout studies in mice also suggest that this kinase may be involved in neuropathic pain development. Defects in this protein have been associated with neurodegenerative disorder spinocerebellar ataxia-14 (SCA14). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
PRKCG Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia type 14
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.01).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.523 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002739.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKCG
NM_002739.5
MANE Select
c.939+1009C>G
intron
N/ANP_002730.1P05129-1
PRKCG
NM_001316329.2
c.939+1009C>G
intron
N/ANP_001303258.1A0A804HIU5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKCG
ENST00000263431.4
TSL:1 MANE Select
c.939+1009C>G
intron
N/AENSP00000263431.3P05129-1
PRKCG
ENST00000682028.1
c.939+1009C>G
intron
N/AENSP00000507230.1A0A804HIU5
PRKCG
ENST00000683513.1
c.939+1009C>G
intron
N/AENSP00000506809.1A0A804HHY0

Frequencies

GnomAD3 genomes
AF:
0.439
AC:
66665
AN:
151746
Hom.:
14781
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.488
Gnomad AMI
AF:
0.451
Gnomad AMR
AF:
0.453
Gnomad ASJ
AF:
0.430
Gnomad EAS
AF:
0.416
Gnomad SAS
AF:
0.542
Gnomad FIN
AF:
0.454
Gnomad MID
AF:
0.449
Gnomad NFE
AF:
0.400
Gnomad OTH
AF:
0.433
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.439
AC:
66732
AN:
151864
Hom.:
14805
Cov.:
32
AF XY:
0.444
AC XY:
32942
AN XY:
74208
show subpopulations
African (AFR)
AF:
0.488
AC:
20201
AN:
41398
American (AMR)
AF:
0.453
AC:
6911
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.430
AC:
1493
AN:
3470
East Asian (EAS)
AF:
0.416
AC:
2140
AN:
5148
South Asian (SAS)
AF:
0.540
AC:
2595
AN:
4804
European-Finnish (FIN)
AF:
0.454
AC:
4788
AN:
10542
Middle Eastern (MID)
AF:
0.445
AC:
130
AN:
292
European-Non Finnish (NFE)
AF:
0.400
AC:
27148
AN:
67940
Other (OTH)
AF:
0.435
AC:
916
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1950
3899
5849
7798
9748
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
620
1240
1860
2480
3100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.420
Hom.:
1696
Bravo
AF:
0.438
Asia WGS
AF:
0.509
AC:
1771
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
1.8
DANN
Benign
0.51
PhyloP100
-0.92
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8103851; hg19: chr19-54397654; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.